Isidoro Feliciello | Biochemistry, Genetics and Molecular Biology | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Isidoro Feliciello
University of Naples Federico II, Italy

Isidoro Feliciello
Affiliation University of Naples Federico II
Country Italy
Scopus ID 6506469897
Documents 42
Citations 986
h-index 17
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Forensic Scientist Awards
ORCID 0000-0002-2588-9366

Isidoro Feliciello is a researcher affiliated with the University of Naples Federico II whose scholarly work contributes to the fields of molecular biology, genetics, epigenetics, genome regulation, and biomedical research. His publication record demonstrates sustained engagement with investigations involving satellite DNA, gene expression regulation, cancer biomarkers, retrotransposons, and microbial biotechnology. Through peer-reviewed publications and collaborative scientific studies, he has contributed to advancing understanding of molecular mechanisms relevant to human health and disease.[1]

Abstract

This article presents an academic overview of Isidoro Feliciello and his research contributions in molecular biology and genetics. His work encompasses investigations into alpha-satellite DNA, genome regulation, cancer-related biomarkers, transcriptional control mechanisms, and translational biomedical applications. Recent studies have explored extracellular alpha-satellite DNA as a potential biomarker for bladder cancer detection and the regulatory effects of alpha-satellite transcripts on gene expression.[2]

Keywords

Alpha-Satellite DNA, Molecular Genetics, Gene Regulation, Cancer Biomarkers, Epigenetics, Digital PCR, Genome Biology, Biomedical Research.

Introduction

Research in biochemistry and molecular genetics continues to expand knowledge regarding genomic organization, transcriptional regulation, and disease mechanisms. Within this context, Isidoro Feliciello has contributed to studies that investigate repetitive DNA sequences, cellular regulatory pathways, and molecular indicators associated with disease diagnosis and progression.[3]

Research Profile

According to available scholarly metrics, the researcher has produced 42 indexed documents with 986 citations and an h-index of 17. His academic portfolio reflects interdisciplinary engagement spanning molecular biology, genetics, cancer biology, nucleic acid regulation, and biotechnology. Publications appear in recognized international journals and demonstrate continued participation in contemporary scientific discourse.[1]

Research Contributions

  • Investigation of alpha-satellite DNA dynamics and biological functions.
  • Research on transcriptional regulation and gene expression mechanisms.
  • Development of molecular approaches for cancer biomarker identification.
  • Studies involving genome integration, retrotransposons, and nucleic acid biology.
  • Contributions to antimicrobial and biotechnology-related applications.

Publications

Selected publications include studies on extracellular alpha-satellite DNA as a candidate biomarker for bladder cancer detection, downregulation of gene expression by alpha-satellite transcripts, chemoresistance mechanisms involving G-quadruplex ligands, antibacterial effects of phenylboronic acid, and analyses concerning polyadenylation and LINE-1 retrotransposons.[2]

Research Impact

The citation profile and publication record indicate meaningful scholarly visibility within molecular biology and genetics. Research outputs address biologically relevant questions concerning genomic structure, gene regulation, cancer diagnostics, and translational biomedical applications. Such contributions support ongoing scientific efforts aimed at improving understanding of complex cellular processes and disease-related molecular signatures.[4]

Award Suitability

The Innovative Research Award recognizes individuals demonstrating sustained scholarly productivity, scientific originality, and measurable research impact. Based on publication activity, citation performance, and contributions to molecular genetics and biomedical research, Isidoro Feliciello exhibits characteristics consistent with the objectives of the International Forensic Scientist Awards recognition framework. His work reflects continued engagement with innovative scientific questions and emerging molecular methodologies.[5]

Conclusion

Isidoro Feliciello’s research portfolio demonstrates sustained contributions to molecular biology, genetics, and biomedical sciences. Through studies addressing genome regulation, cancer biomarkers, and nucleic acid biology, he has contributed to the advancement of scientific understanding in several interconnected research domains. His scholarly record provides a foundation for recognition within international research and innovation award programs.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Isidoro Feliciello, Author ID 6506469897. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506469897
  2. Feliciello, I. et al. (2026). Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection.
    https://doi.org/10.3390/ijms27156834
  3. Feliciello, I. et al. (2025). Downregulation of Gene Expression by Alpha Satellite Transcripts.
    https://doi.org/10.3390/ijms262211204
  4. Feliciello, I. et al. (2025). Reversing uL3-mediated Chemoresistance Through Synergistic Combination of 5-FU and G-Quadruplex Ligands.
    https://doi.org/10.1093/narcan/zcaf046
  5. Feliciello, I. et al. (2025). Antibacterial Effect of Phenylboronic Acid on Escherichia coli.
    https://doi.org/10.17113/ftb.63.01.25.8771
  6. Feliciello, I. et al. (2025). Role of Polyadenylation in mRNA Genome Integration via LINE-1 Retrotransposons.
    https://doi.org/10.31083/FBS26335

Daniela Muntele-Hendreș | Health Professions | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Daniela Muntele-Hendreș
Alexandru Ioan Cuza University from Iasi, Romania
Daniela Muntele-Hendreș
Affiliation Alexandru Ioan Cuza University from Iasi
Country Romania
Scopus ID 8628276600
Documents 5
Citations 224
h-index 4
Subject Area Health Professions
Event International Forensic Scientist Awards

The Innovative Research Award recognition highlights scholarly contributions that demonstrate originality, methodological rigor, and measurable impact within a specialized field of research. Daniela Muntele-Hendreș, affiliated with Alexandru Ioan Cuza University from Iasi, has contributed to contemporary health professions and psychosocial research through studies addressing health literacy, burnout, quality of life, aging, environmental attitudes, and psychological well-being.[1] Her published and ongoing research reflects interdisciplinary engagement and an evidence-based approach to understanding complex human health and behavioral outcomes.[2]

Abstract

Daniela Muntele-Hendreș has developed a research portfolio focused on psychosocial health, medical well-being, aging, and health literacy. Her scholarly work investigates the factors influencing professional satisfaction, quality of life, environmental responsibility, and health outcomes across diverse populations. Recent studies have examined physician burnout, cancer health literacy assessment, meaning in life among older adults, and psychological determinants of social adaptation.[3] These contributions support evidence-informed practices within health professions and behavioral sciences.

Keywords

Health Professions, Burnout Research, Health Literacy, Quality of Life, Aging Studies, Psychosocial Oncology, Environmental Attitudes, Cross-Generational Research, Psychological Assessment, Behavioral Health.

Introduction

Research in health professions increasingly emphasizes the integration of psychological, social, and behavioral determinants of health. Daniela Muntele-Hendreș has contributed to this domain by investigating mechanisms that influence professional performance, patient-centered outcomes, and quality of life. Her work reflects contemporary priorities in healthcare research, including mental health resilience, literacy assessment, and healthy aging.[4]

Research Profile

The research profile of Daniela Muntele-Hendreș is characterized by interdisciplinary inquiry spanning health psychology, gerontology, psychosocial oncology, and behavioral sciences. According to Scopus metrics, the author profile records 5 indexed documents, 224 citations, and an h-index of 4.[1] Her studies employ quantitative methodologies, psychometric validation approaches, systematic reviews, and cross-sectional analyses to address real-world health challenges.

Research Contributions

  • Investigation of physician burnout profiles and occupational satisfaction.
  • Development and validation of health literacy assessment instruments.
  • Research on meaning in life and quality of life among older adults.
  • Analysis of environmental attitudes and responsibility toward future generations.
  • Studies addressing childhood trauma and psychosocial adaptation in foster care populations.

Publications

  • Distinct Burnout Profiles in Physicians (2026).
  • Meaning in Life as a Resource for Quality of Life in Older Adulthood (2026).
  • Psychometric Validation of the Romanian Version of CHLT-30 (2026).
  • Meaning in Life as a Mediator Between Conservatism and Quality of Life (2026).
  • Death Salience and Pro-Environmental Attitudes (2025).
  • Childhood Trauma and Symptoms in Foster Care Youth (2025).

Research Impact

The research output demonstrates measurable academic visibility through citation activity and engagement within the health professions community. The integration of psychometric validation, systematic evidence synthesis, and applied health research contributes to the reliability and practical relevance of the findings.[5] The studies provide insights that may inform clinical practice, health education, and public health interventions.

Award Suitability

Daniela Muntele-Hendreș demonstrates attributes commonly associated with innovative research recognition, including interdisciplinary scholarship, methodological rigor, and contributions to emerging health challenges. Her work addresses relevant societal issues while advancing scientific understanding in health-related disciplines.[6]

Conclusion

Through research on health literacy, physician well-being, aging, environmental responsibility, and psychosocial outcomes, Daniela Muntele-Hendreș has established a focused and evolving academic profile. The documented publication record, citation impact, and engagement with contemporary health issues support recognition within scholarly and professional communities.

References

  1. Elsevier. (n.d.). Scopus author details: Daniela Muntele-Hendreș, Author ID 8628276600. Scopus.
    https://www.scopus.com/pages/authors/8628276600
  2. Muntele-Hendreș, D., Clapon, G.-M., & Cojocaru, C. D. (2026). Distinct Burnout Profiles in Physicians.
    https://doi.org/10.3390/ijerph23080967
  3. Pitiruț, I. B., Ogunbode, C., Muntele-Hendreș, D., & Enea, V. (2025). Death Studies.
    https://doi.org/10.1080/07481187.2025.2605159
  4. Corlățianu, M. I., Măirean, C., & Muntele-Hendreș, D. (2025). Deviant Behavior.
    https://doi.org/10.1080/01639625.2025.2564935
  5. Cojocaru, L., Azoicăi, D., Muntele-Hendreș, D., & Șoponaru, C. (2026). Medical-Surgical Journal.
  6. International Forensic Scientist Awards. (n.d.). Award Information Portal.
    forensicscientist.org

Estíbaliz Ugalde Zárraga | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Estíbaliz Ugalde Zárraga
Affiliation Hospital Universitario de Basurto
Country Spain
Scopus ID 8588014900
Documents 9
Citations 23
h-index 3
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0003-3877-3642

Estíbaliz Ugalde Zárraga

Hospital Universitario de Basurto, Spain

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate scientific originality, methodological quality, and measurable research impact. Estíbaliz Ugalde Zárraga has contributed to the fields of clinical microbiology and infectious diseases through peer-reviewed publications addressing bacterial pathogens, antimicrobial resistance, zoonotic infections, and diagnostic microbiology. Her published studies support evidence-based clinical practice and improve understanding of uncommon infectious conditions encountered in healthcare settings.[1]

Abstract

Estíbaliz Ugalde Zárraga has established a developing research profile focused on infectious diseases, diagnostic microbiology, and clinically significant bacterial pathogens. Her publications emphasize accurate diagnosis, antimicrobial resistance surveillance, and uncommon infectious presentations that contribute to improved patient management. Recent studies include investigations involving Shigella sonnei carrying blaCTX-M-15, Pasteurella canis, Neisseria animaloris, Prevotella oris, Whipple’s disease, and Capnocytophaga canis. Collectively, these works provide clinically relevant observations that strengthen microbiological knowledge and support evidence-based healthcare decision-making.[2]

Keywords

Clinical Microbiology, Infectious Diseases, Antimicrobial Resistance, Diagnostic Medicine, Bacterial Pathogens, Medicine and Health Sciences.

Introduction

Modern clinical microbiology depends upon timely identification of infectious organisms and accurate reporting of emerging resistance mechanisms. Research addressing rare infections and unusual clinical presentations contributes valuable evidence to physicians and laboratory specialists. Through publications in recognized medical journals, Estíbaliz Ugalde Zárraga has participated in expanding scientific understanding of infectious disease diagnosis while supporting continuous improvements in microbiological practice.[3]

Research Profile

According to the supplied scholarly indicators, the researcher has a Scopus Author ID of 8588014900 with 9 indexed documents, 23 citations, and an h-index of 3. The research portfolio is primarily associated with Medicine and Health Sciences, emphasizing microbiological diagnosis, infectious disease case investigations, antimicrobial resistance, and clinically relevant laboratory findings. Publications demonstrate collaboration within hospital-based research environments and contribute practical observations useful to clinicians and microbiologists.[1]

Research Contributions

  • Reported sexually transmitted Shigella sonnei carrying blaCTX-M-15 among men who have sex with men.
  • Documented clinically significant infections following animal bites involving uncommon bacterial species.
  • Published evidence on serious pleuropulmonary infections caused by Prevotella oris.
  • Contributed case-based knowledge on Whipple’s disease and rare microbiological presentations.
  • Supported clinical microbiology literature through peer-reviewed publications with practical diagnostic relevance.

Publications

Representative publications include First report of Shigella sonnei carrying blaCTX-M-15 (2024), Wound infection caused by Pasteurella canis and Neisseria animaloris after a dog bite (2023), Two cases of Prevotella oris causing serious pleuropulmonary infections (2023), Whipple’s disease with multiple presentation in a rheumatologic patient (2023), and Capnocytophaga canis describing uncommon infection associated with cats. These publications collectively illustrate sustained contributions to infectious disease literature.[4]

Research Impact

The available publication metrics indicate measurable scholarly visibility within the medical research community. Citation activity reflects the scientific relevance of published findings, while the research topics address practical healthcare challenges involving pathogen identification, antimicrobial resistance, and infectious disease management. Such work contributes to the ongoing advancement of laboratory medicine and evidence-based clinical practice.[5]

Award Suitability

Based on the documented scholarly record, publication portfolio, and contributions to clinical microbiology, the researcher demonstrates characteristics consistent with consideration for an Innovative Research Award. The combination of peer-reviewed publications, practical diagnostic relevance, and investigation of uncommon infectious conditions illustrates a research profile focused on advancing medical knowledge while supporting improved patient care.[1]

Conclusion

Estíbaliz Ugalde Zárraga has contributed to contemporary clinical microbiology through research addressing infectious diseases of medical importance. Her scholarly output, supported by indexed publications and citation metrics, reflects continued engagement in clinically applicable research. The documented body of work demonstrates scientific rigor, collaboration, and commitment to advancing knowledge within Medicine and Health Sciences.

References

  1. Elsevier. (n.d.). Scopus author details: Estíbaliz Ugalde Zárraga, Author ID 8588014900. Scopus.
    https://www.scopus.com/pages/authors/8588014900
  2. Ugalde Zárraga E., et al. (2024). First report of Shigella sonnei carrying blaCTX-M-15. Infection.
    https://doi.org/10.1007/s15010-024-02341-7
  3. Revista Española de Quimioterapia. Wound infection caused by Pasteurella canis and Neisseria animaloris after a dog bite.
    https://doi.org/10.37201/req/035.2023
  4. Revista Española de Quimioterapia. Two cases of Prevotella oris causing serious pleuropulmonary infections.
    https://doi.org/10.37201/req/001.2023
  5. Enfermedades Infecciosas y Microbiología Clínica. Capnocytophaga canis, una causa poco común de infección causada por gatos.
    https://doi.org/10.1016/j.eimc.2022.05.010

Charles Timumpi Nignang | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Charles Timumpi Nignang
Affiliation University for Development Studies
Country Ghana
Documents 3
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0009-0005-8929-5267

Charles Timumpi Nignang

University for Development Studies, Ghana

Charles Timumpi Nignang is a researcher affiliated with the University for Development Studies, Ghana, whose scholarly work focuses on medicine and public health with particular emphasis on adolescent health, reproductive health, qualitative health research, and community-centered healthcare interventions. His recent peer-reviewed publications contribute evidence supporting equitable access to healthcare services through culturally appropriate and participatory research approaches. His research demonstrates the importance of engaging young people, healthcare professionals, and families in designing sustainable health interventions within resource-limited settings. These contributions provide valuable insights for healthcare policy, implementation science, and preventive medicine while strengthening evidence-based public health practice.[1]

Abstract

This article summarizes the academic profile and research contributions of Charles Timumpi Nignang. His published studies emphasize youth sexual and reproductive health, cervical cancer prevention, peer-led health education, and qualitative healthcare research in Northern Ghana. Through collaborative and evidence-based investigations, his work contributes practical knowledge for strengthening public health services, promoting inclusive healthcare delivery, and informing future intervention strategies within diverse community settings.[2]

Keywords

Medicine, Public Health, Adolescent Health, Reproductive Health, Qualitative Research, Cervical Cancer Prevention, Peer-Led Intervention, Community Health, Ghana.

Introduction

Healthcare research addressing youth engagement and preventive medicine has become increasingly important in improving long-term health outcomes. Charles Timumpi Nignang’s research aligns with these priorities by exploring barriers to healthcare access, promoting participatory intervention design, and evaluating culturally appropriate approaches that support equitable healthcare delivery.[3]

Research Profile

His current scholarly record includes three peer-reviewed journal publications in internationally recognized medical journals. The research primarily applies qualitative methodologies to understand healthcare experiences among adolescents, healthcare workers, and families. These investigations support evidence-informed decision-making while contributing to implementation research in reproductive and preventive healthcare.[1]

Research Contributions

  • Investigated youth access to sexual and reproductive health services.
  • Developed formative evidence for peer-led contraceptive counselling programs.
  • Examined family-centered approaches supporting cervical cancer prevention.
  • Applied qualitative methods to strengthen community-based healthcare interventions.

Publications

  • A Qualitative Study on Youth and Healthcare Provider Perspectives on Youth Access to Sexual and Reproductive Health Services in Northern Ghana.
  • Co-Designing a Peer-Led Contraceptive Counselling Program in Northern Ghana.
  • My Wife’s Healthcare Is My Healthcare.

Research Impact

The published studies provide evidence supporting adolescent reproductive health services, peer-supported counselling models, and family engagement in preventive healthcare. These contributions are relevant to public health practitioners, researchers, policymakers, and healthcare organizations seeking practical approaches for improving health outcomes within community settings.[4]

Award Suitability

Based on the available scholarly record, Charles Timumpi Nignang demonstrates active research engagement in medicine and health sciences through peer-reviewed publications addressing significant public health challenges. His research aligns with the objectives of the Innovative Research Award by emphasizing scientific evidence, healthcare innovation, community participation, and knowledge translation.[5]

Conclusion

Charles Timumpi Nignang’s publications contribute to contemporary discussions surrounding adolescent health, preventive medicine, and community-centered healthcare delivery. His qualitative research offers practical evidence that may support future public health interventions and collaborative healthcare initiatives in Ghana and similar settings.

References

  1. Elsevier. (n.d.).  Author details: Charles Timumpi Nignang
  2. International Journal of Environmental Research and Public Health. (2026). A Qualitative Study on Youth and Healthcare Provider Perspectives on Youth Access to Sexual and Reproductive Health Services in Northern Ghana.
    https://doi.org/10.3390/ijerph23070915
  3. Journal of Adolescent Health. (2026). Co-Designing a Peer-Led Contraceptive Counselling Program in Northern Ghana.
    https://doi.org/10.1016/j.jadohealth.2025.12.221
  4. Cancer Control. (2026). My Wife’s Healthcare Is My Healthcare.
    https://doi.org/10.1177/10732748261448259
  5. International Forensic Scientist Awards. (2026). Innovative Research Award.
    forensicscientist.org

Aby Joseph | Genetics and Genomics | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Aby Joseph | Genetics and Genomics | Best Researcher Award

Amity University, Dubai | United Arab Emirates

Dr. Aby Joseph is a distinguished forensic science scholar whose research has significantly advanced forensic DNA quality management, crime scene biology, and international forensic accreditation systems. His work focuses on enhancing the accuracy and integrity of forensic DNA workflows through contamination control strategies, DNA quality improvement models, and ISO/IEC 17025–aligned quality frameworks. Notably, his Scopus-indexed scholarly footprint includes 7 publications, 3 citations, and an h-index of 1, reflecting a steadily growing impact in the forensic science research community. Dr. Aby Joseph has authored influential peer-reviewed articles in leading journals such as the Journal of Forensic Science and Medicine, Problems of Forensic Science, Multidisciplinary Science Journal, and the Journal of Communicable Diseases. His research spans integrated ISO-centric quality systems, comparative analyses of national forensic DNA frameworks, contamination mitigation, and forensic interventions in zoonotic disease transmission. In addition to journal publications, he has contributed book chapters with Nova Science Publishers and Springer, covering forensic entomology and advanced investigative methodologies. His scholarly presence is further strengthened by case studies, conference papers, and invited presentations on topics such as GCC forensic DNA standard harmonization, parentage testing complexities, disaster victim identification, wildlife crime, and advancements in forensic genetics. As a keynote speaker, session chair, and panel moderator at major international conferences, he has demonstrated notable academic leadership. Dr. Aby Joseph’s research contributions continue to shape forensic quality assurance, DNA analysis standards, and evidence-based forensic innovation worldwide.

Profiles: Scopus | ORCID

Featured Publications

  • Joseph, A., Rao, I., & Singh, N. (2025). Contamination control and quality assurance in forensic DNA analysis: Lessons from the UK and Indian system. Journal of Forensic Science and Medicine, 11(3), 163–169.

  • Joseph, A. (2024). Enhancing forensic DNA quality: A comprehensive review of integrated ISO-centric standards from the crime scene to the courtroom. Problems of Forensic Science.

  • Joseph, A. (2025). Towards standardized forensic DNA practices: Comparative analysis of forensic DNA quality management systems in India and the UK. Multidisciplinary Science Journal.

Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Wannan Medical College | China

Prof. Zhiliang Xu, affiliated with Wannan Medical College, Wuhu, China, is a distinguished molecular biologist and epigenetics researcher whose work focuses on histone ubiquitination, chromatin remodeling, and their implications in neurological disorders, cancer, gametogenesis, and cellular reprogramming. He earned his Ph.D. from the State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences in 2017. According to Scopus, Prof. Zhiliang Xu has authored 11 publications, which have been cited 34 times, and he holds an h-index of 4, demonstrating the impact of his research in the scientific community. His seminal studies elucidated the role of H2B ubiquitination in chromatin relaxation during meiosis and cellular reprogramming, published in journals such as Nucleic Acids Research (2016), Cell Proliferation (2021), and Reproduction (2017). His recent work on neuronal repair, gut-liver axis regulation in diabetes, and genomic approaches to thalassemia has been featured in FASEB Journal (2025), Annals of Hematology (2025), and Neuroscience Letters (2025). Prof. Zhiliang Xu leads multiple high-impact national and provincial research projects, serves as a peer reviewer for journals including Scientific Reports and Neurochemical Research, and evaluates theses for graduate and doctoral candidates. Recognized with the 2021 National Maternal and Child Health Science and Technology Award (First Prize), the 2022 Guangzhou High-level Talent Award, and the 2024 Outstanding Young Talent honor in Anhui Province, Prof. Zhiliang Xu continues to advance fundamental understanding of chromatin biology and epigenetic regulation, exemplifying excellence, mentorship, and translational scientific impact, making him an outstanding candidate for the Best Researcher Award.

Profile: Scopus | ORCID

Featured Publications

1. Shi, L., Yan, X., Xia, Y., Zhao, Y., Zhu, X., Li, Q., & Xu, Z. (2025). Beyond transfusions and transplants: Genomic innovations rewriting the narrative of thalassemia. Annals of Hematology.

2. Zhang, Y., Wang, J., Huang, S., Liu, M., Zhao, Y., Xu, Z., & Zhu, X. (2025). Electroacupuncture preconditioning alleviates cortical neuronal injury in cerebral ischemia-reperfusion by rebalancing HES1 and NF-κB expression. Neuroreport.

3. Yan, X., Shi, L., Zhu, X., Zhao, J., Zhao, Y., Luo, J., Li, Q., & Xu, Z. (2025). From microbial homeostasis to systemic pathogenesis: A narrative review on gut flora’s role in neuropsychiatric, metabolic, and cancer disorders. Journal of Inflammation Research.

4. Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025). Neurodegenerative diseases and neuroinflammation-induced apoptosis. Open Life Sciences.

5. Li, Q., Zhang, L., Sun, Y., Du, Z., Xu, S., Wang, X., Wei, S., Tao, Y., Li, B., Jiang, J., Di, G., Huang, Y., & Xu, Z. (2025). p53 modulates the gut-liver axis via PI3K/AKT/Wnt signaling pathways in type 2 diabetes. FASEB Journal.

6. Li, Q., Yan, X., Zhao, Y., Xu, Z., & Zhu, X. (2025). Paeonol mitigates chronic stress-induced amygdalar neuronal damage through glycogen synthase kinase-3β/calcineurin axis regulation of synaptic plasticity. Neuroreport.

7. Zhu, X., Zhang, Y., Yan, X., Zhao, Y., Shi, L., Sun, Z., Meng, K., Zong, Y., Li, Q., & Xu, Z. (2025). Paeonol facilitates the repair of neuronal damage in the mPFC caused by chronic stress via the Rho GTPases-cofilin1 signaling pathway. Neuroscience Letters, 138329.

Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Chiba University | China

Dr. Meng Ning is an accomplished researcher at Chiba University, Japan, recognized for her pioneering work in the epigenetic regulation of cancer. She has made substantial contributions to understanding the non-catalytic roles of chromatin regulators, particularly in gastric cancer. Her expertise bridges molecular biology and clinical gastrointestinal oncology, enabling her to translate laboratory discoveries into potential therapeutic strategies. Meng Ning is known for her meticulous experimental design, innovative application of genome-editing technologies, and dedication to advancing cancer research through both independent studies and collaborative projects.

Professional Profile

ORCID

Education

Dr. Meng Ning completed her doctoral studies at Chiba University, Japan, where she focused on elucidating novel mechanisms of cancer progression. Her Ph.D. research revealed a previously unrecognized non-catalytic function of SETD1A in gastric cancer via the E2F4–TAF6 axis. Employing advanced techniques including transcriptomics, epigenomics, and genome-editing approaches, she was able to demonstrate this mechanism independently of traditional methyltransferase activity. Her academic training combines rigorous laboratory research with a strong foundation in clinical oncology, preparing her to conduct translational studies that link fundamental discoveries with therapeutic potential.

Experience

Dr. Meng Ning has extensive experience in both experimental and translational cancer research. She has collaborated with the Department of Pathology at the University of Tokyo to analyze clinical gastric cancer specimens, integrating molecular findings with patient data. Her work spans NGS-based studies, CRISPR genome editing, and multi-omics analyses, reflecting a versatile approach to cancer biology. Beyond laboratory research, she has contributed to the mentorship of junior researchers, participated in collaborative projects across institutions, and actively engaged in the scientific community through professional society memberships and research networks.

Research Interests

Dr. Meng Ning’s primary research interest lies in the epigenetic regulation of cancer, with a focus on non-catalytic functions of chromatin regulators. She investigates how these regulators influence tumor proliferation, cellular signaling, and transcriptional networks using advanced molecular biology techniques. Her research integrates next-generation sequencing, genome editing, and integrative bioinformatics to identify novel mechanisms underlying cancer progression. By connecting these molecular insights with clinical oncology, she aims to identify potential therapeutic targets and contribute to the development of innovative cancer treatments.

Awards

Dr. Meng Ning is nominated for the Best Researcher Award in recognition of her outstanding contributions to cancer epigenetics and translational oncology. Her research has introduced novel concepts in understanding chromatin regulator function and tumor biology, demonstrating originality, technical excellence, and significant impact in the field. Her dedication to advancing cancer research through rigorous experimentation and collaborative endeavors positions her as a leading researcher in her discipline.

Publications

Dr. Meng Ning has authored several high-impact, SCI-indexed publications as first or contributing author. Her work demonstrates innovative methodologies and deep insights into the molecular mechanisms of cancer:

Title: Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4–TAF6 axis in the cell cycle
Journal: Cell Death & Disease
Published on: 2025-08-23

Title: Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
Journal: Breast Cancer Research
Published on: 2025-08-11

Title: Integrated enhancer regulatory network by enhancer–promoter looping in gastric cancer
Journal: NAR Cancer
Published on: 2024-04-08

Conclusion

Dr. Meng Ning exemplifies excellence in scientific research through her innovative studies in cancer epigenetics and her commitment to translational application. Her work bridges basic molecular discoveries and clinical oncology, offering new avenues for therapeutic development. With a combination of technical skill, collaborative engagement, and visionary research, Meng Ning stands out as a highly deserving candidate for the Best Researcher Award. Her contributions not only advance the understanding of cancer biology but also inspire ongoing innovation in epigenetic and translational research.

Dongmei Li | Genetics | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Dongmei Li | Genetics | Best Researcher Award

Professor | University of Rochester | United States

Dr. Dongmei Li is a distinguished professor at the University of Rochester School of Medicine & Dentistry, where she is actively involved in clinical and translational research. She also holds affiliations with the Goergen Institute for Data Science. With expertise spanning biostatistics, public health sciences, and data science, Dr. Li has made significant contributions to advancing health research through statistical modeling and innovative data analysis methods.

Profile

Scopus

Orcid

Strengths for the Awards

  • Academic and Professional Excellence:
    • Dr. Li holds a Ph.D. in Biostatistics and advanced training in biomedical data science, genetics, and public health, making her expertise highly interdisciplinary.
    • Current roles as Professor and Program Director at the University of Rochester underscore her leadership in academia.
  • Diverse Research Contributions:
    • Dr. Li’s research spans clinical and translational sciences, public health, and biostatistics.
    • Extensive mentorship for students and postdocs, with multiple mentees achieving national recognition.
  • Recognition and Honors:
    • Recipient of numerous awards, such as the David P. Byar Young Investigator Travel Award and mentorship-related accolades for students.
    • Multiple travel grants and special merit awards signify her influence in the research community

Education 🎓

Dr. Li’s academic journey began with a BS in Pomology from Laiyang Agricultural College in China, followed by an MS in Biophysics from China Agricultural University. She later pursued advanced training in the United States, earning an MS in Statistics and a PhD in Biostatistics from The Ohio State University. Her academic pursuits reflect a deep commitment to integrating quantitative methods into biological and health research.

Experience 🏫

Dr. Li’s professional career includes faculty appointments at the University of Hawaii at Manoa, where she developed and taught biostatistics courses, and her current role at the University of Rochester. Over the years, she has advanced from assistant to professor, conducting groundbreaking research in statistical methods for health data and mentoring students and early-career researchers.

Research Interests On Genetics 🔍

Dr. Li’s research focuses on applying statistical models to complex health data, including biomarker discovery, tobacco research, and diabetes studies. She is particularly interested in integrating machine learning with traditional biostatistics to address challenges in health disparities and population health. Her interdisciplinary approach bridges the gap between health sciences and computational methods.

Awards 🏆

Dr. Li has been recognized for her contributions to research and mentoring, receiving accolades such as the David P. Byar Young Investigator Travel Award and the National Student Employee of the Year Award for her mentees. Her numerous scholarships and travel awards highlight her dedication to fostering collaborative research and innovation.

Publications 📚

  • “Assessing associations between individual-level social determinants of health and COVID-19 hospitalizations: Investigating racial/ethnic disparities among people living with human immunodeficiency virus (HIV) in the U.S. National COVID Cohort Collaborative (N3C)”
    • Authors: Dimple Vaidya, Kenneth J. Wilkins, Eric Hurwitz, Jessica Y. Islam, Dongmei Li, Jing Sun, Sandra E. Safo, Jennifer M. Ross, Shukri Hassan, Elaine Hill, et al.
    • Publication Year: 2024
    • Citations: As of now, this publication has not been cited by other works.
  • “Public Perceptions of Very Low Nicotine Content on Twitter: Observational Study”
    • Authors: Zidian Xie, Xinyi Liu, Xubin Lou, Dongmei Li
    • Publication Year: 2024
    • Citations: This study has been cited by the following publications:
      • Tracy T. Smith, Richard J. O’Connor, K. Michael Cummings, Alex C. Liber, “Tobacco Control Strategies,” International Encyclopedia of Public Health, 2025.
      • Kiana L. Fall, Robin M. Forbes-Lorman, “No effect on behavior in a pilot study investigating the role of progesterone in nicotine withdrawal in female rats,” BIOS, 2024.
      • Piyush Anand, Vrinda Kadiyali, “Frontiers: Smoke and Mirrors: Impact of E-cigarette Taxes on Underage Social Media Posting,” Marketing Science, 2024.
      • Onyema Greg Chido-Amajuoyi, Dale S. Mantey, Efehi Igbinomwanhia, Onyinye Omega-Njemnobi, Henry Onyeaka, Robert K. Yu, Israel Agaku, Sanjay Shete, “Perceptions of the Addictiveness of Low-Nicotine Cigarettes Versus Typical Cigarettes and Exposure to Tobacco Industry-Sponsored Corrective Campaign,” Substance Use & Misuse, 2024.
      • Carlos Blanco, Benjamin Apelberg, Brian A. King, Wilson M. Compton, “Opportunities for advancing science to inform tobacco regulation in an evolving tobacco landscape,” Molecular Psychiatry, 2024.
  • “Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic”
    • Authors: Lisette Alcantara Sanchez, Eloy Alvarez Guerra, Dongmei Li, Samantha M. King, Shannon P. Hilchey, Qian Zhou, Stephen Dewhurst, Kevin Fiscella, Martin S. Zand
    • Publication Year: 2024
    • Citations: This publication has not been cited by other works to date.
  • “Marker gene fishing for single-cell data with complex heterogeneity”
    • Authors: Yiren Shao, Qi Gao, Liuyang Wang, Dongmei Li, Andrew B. Nixon, Cliburn Chan, Qi-Jing Li, Jichun Xie
    • Publication Year: 2024
    • Citations: Currently, there are no citations for this preprint.
  • “Associations of County-Level Social Determinants of Health with COVID-19 Related Hospitalization Among People with HIV: A Retrospective Analysis of the U.S. National COVID Cohort Collaborative (N3C)”
    • Authors: Jessica Y. Islam, Eric Hurwitz, Dongmei Li, Marlene Camacho-Rivera, Jing Sun, Sandra Safo, Jennifer M. Ross, Kenneth Wilkins, Shukri Hassan, Elaine L. Hill, et al.
    • Publication Year: 2024
    • Citations: This article has not been cited by other publications yet.
  • “Discussion of Heated Tobacco Products on Twitter Following IQOS’s Modified-Risk Tobacco Product Authorization and US Import Ban: Content Analysis”
    • Authors: Minji Kim, Julia Vassey, Dongmei Li, Artur Galimov, Eileen Han, Matthew G. Kirkpatrick, Cassandra A. Stanton, Jenny E. Ozga, Sarah Lee, Jennifer B. Unger
    • Publication Year: 2024
    • Citations: No citations have been recorded for this study so far.
  • “Temporal and Thematic Analysis of Promotional Waterpipe-Related Posts on Twitter/X in the US”
    • Authors: Puhua Ye, Mengwei Wu, Yiwei Han, Yuka Shimazaki, Jennifer Cornacchione Ross, Erin L. Sutfin, Dongmei Li, Zidian Xie
    • Publication Year: 2024
    • Citations: This preprint has not been cited by other works.
  • “Public Perception of the Tobacco 21 Amendment on Twitter in the United States: Observational Study”
    • Authors: Liane M. Schneller-Najm, Zidian Xie, Jiarui Chen, Sarah Lee, Emily Xu, Dongmei Li
    • Publication Year: 2024
    • Citations: There are no citations for this study at this time.
  • “Public Perceptions of the Food and Drug Administration’s Regulatory Authority Over Synthetic Nicotine on Twitter: Observational Study”
    • Authors: Jonathan Zou, Juan Ramon Feliciano, Zidian Xie, Dongmei Li
    • Publication Year: 2024
    • Citations: This publication has not been cited by other works to date.

Conclusion 🌟

Dr. Dongmei Li’s extensive expertise, innovative research, and dedication to mentoring make her a valuable asset to the academic and scientific community. Her work continues to impact the fields of biostatistics and public health, fostering collaboration across disciplines and inspiring the next generation of researchers.